Similar articles

• Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture.

  Cadarette SM, Katz JN, Brookhart MA, Stürmer T, Stedman MR, Solomon DH. Cadarette SM, et al. Ann Intern Med. 2008 May 6;148(9):637-46. doi: 10.7326/0003-4819-148-9-200805060-00003. Ann Intern Med. 2008. PMID: 18458276 Free PMC article.
• Long-term experience with alendronate in the treatment of osteoporosis.

  Hochberg MC, Rizzoli R. Hochberg MC, et al. Expert Opin Pharmacother. 2006 Jun;7(9):1201-10. doi: 10.1517/14656566.7.9.1201. Expert Opin Pharmacother. 2006. PMID: 16732706 Review.
• [Osteoporosis].

  Bartl R. Bartl R. Internist (Berl). 2002 Dec;43(12):1529-30, 1533-43. doi: 10.1007/s00108-002-0758-7. Internist (Berl). 2002. PMID: 12607392 Review. German. No abstract available.
• Osteoporosis treatment and fracture incidence: the ICARO longitudinal study.

  Adami S, Isaia G, Luisetto G, Minisola S, Sinigaglia L, Silvestri S, Agnusdei D, Gentilella R, Nuti R; ICARO Study Group. Adami S, et al. Osteoporos Int. 2008 Aug;19(8):1219-23. doi: 10.1007/s00198-008-0566-6. Epub 2008 Feb 20. Osteoporos Int. 2008. PMID: 18286217
• [Correlation between studies and general practice].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2006 Nov 16;148(46):49. MMW Fortschr Med. 2006. PMID: 17615791 German. No abstract available.